Exelixis (EXEL) Reports Q3 Earnings: What Key Metrics Have to Say

Core Insights - Exelixis reported $539.54 million in revenue for Q3 2024, a 14.3% year-over-year increase, with an EPS of $0.47 compared to $0.10 a year ago, exceeding both revenue and EPS consensus estimates [1][3] Revenue Performance - Net product revenue was $478.06 million, surpassing the average estimate of $443.69 million by 10 analysts, reflecting a 12.1% increase year-over-year [3] - CABOMETYX generated $475.70 million in revenue, exceeding the seven-analyst average estimate of $438.54 million [3] - COMETRIQ revenue was $2.40 million, falling short of the $4.32 million estimate from seven analysts [3] - License revenue reached $60.24 million, significantly above the four-analyst average estimate of $42.11 million, marking a 42.2% year-over-year increase [3] - Collaboration services revenue was $1.24 million, below the $3.17 million average estimate from three analysts, representing a 59.3% decline year-over-year [3] Stock Performance - Exelixis shares have returned +9.8% over the past month, outperforming the Zacks S&P 500 composite's +1.7% change, with a Zacks Rank 2 (Buy) indicating potential for further outperformance [4]